Şanlı, Fatma et al. “The AKT Antagonist AZD5363 Suppresses Features Associated With Cancer Progression in Human Larynx Cancer Cells”. The European Research Journal 6/5 (September 3, 2020), 380-387. https://doi.org/10.18621/eurj.624088